Carregant...
Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma
In order to facilitate long-term treatment decisions, we aimed to define biomarkers defining the probability of receiving second-line (SL) targeted therapy (TT) in patients with metastatic renal cell carcinoma (mRCC) based on their characteristics present at first-line TT initiation. We analysed 152...
Guardat en:
| Publicat a: | Med Oncol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5940724/ https://ncbi.nlm.nih.gov/pubmed/29737510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12032-018-1148-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|